Humana 2025 Outlook - Search News

News

Suspends 2025 Outlook on higher-than-expected medical costs

UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down

UnitedHealth’s stock cuts the Dow’s price by more than 400 points, as care activity accelerates and Medicare costs remain higher than expected.

Associated Press News on MSN · 2d

UnitedHealth Group CEO steps down as company lowers, then withdraws financial outlook for 2025

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation's largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs. Chairman Stephen Hemsley will become CEO,

Atlanta Journal-Constitution · 2d

UnitedHealth Group CEO steps down; suspends 2025 outlook on higher-than-expected medical costs

Witty will serve as a senior adviser to Hemsley. UnitedHealth said that it suspended its 2025 outlook as medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare were higher ...

14d

Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline

Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, beating the ...

Morningstar15d

Humana Earnings: In-Line Medicare Advantage Utilization Keeps 2025 Outlook Intact

Humana delivered 60% adjusted EPS growth in the quarter and maintained its 2025 outlook. On an adjusted operating profit basis, medical insurance grew 75%, including a better medical loss ratio ...

Stock market today: S&P 500 jumps, set to wipe out 2025 losses as Dow weighed down by UnitedHealth plunge

The euphoria over the US-China trade truce began to fade as investors digested the latest reading on consumer prices.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results